Nearly Half of Oncology Drugs Approved Since 1998 Are Precision Therapies
Cancer patients eligible for precision oncology therapies nearly doubled between 2017 and 2022 PHILADELPHIA – Of the 198 new...
Cancer patients eligible for precision oncology therapies nearly doubled between 2017 and 2022 PHILADELPHIA – Of the 198 new...
The therapy uses a different mechanism than approved KRAS G12C inhibitors and targets multiple RAS mutations beyond KRAS G12C...
Second-generation PRMT5 inhibitor targets synthetic lethality in several cancer types with MTAP loss BOSTON – AMG 193, a second-generation...
PHILADELPHIA – The American Association for Cancer Research (AACR) extends its warmest congratulations to the 15 AACR members who...
Today, the American Association for Cancer Research (AACR) issued the following statement regarding the death of Senator Dianne Feinstein:...
ORLANDO, Fla. – The American Association for Cancer Research (AACR) will award Folakemi T. Odedina, PhD, with the 2023...
ORLANDO, Fla. – Structural racism was associated with increased county-level cancer mortality rates among minority populations compared with whites,...
Survey found that most people are open to participating, and motivation varied by racial and ethnic group ORLANDO, Fla....
Most men in survey were never offered the HPV vaccine ORLANDO, Fla. – A study found multiple gaps in...
Palliative care use increased among all racial/ethnic groups from 2004 to 2020 ORLANDO, Fla. – Despite a steady increase...